A New Conversational AI SaaS Solution for Cancer Clinical Trial Matching

New solution named ‘Tara’ provides embeddable and scalable patient engagement platform for hospitals, health systems and CROs.

Tara Expands Belong’s Proven Clinical Matching Services to Thousands More Patients.

Belong.Life, a leading global provider of high-engagement patient communities and care platforms, today announced the launch of Tara, a SaaS-based conversational AI cancer clinical trial matching platform for health providers and contract research organizations (CROs). The solution is designed to accelerate the process of matching patients with eligible clinical trials, enabling increased recruitment at significantly lower costs. Tara is the second product in Belong’s AI Health Mentor suite of solutions, following the launch of Dave, the world’s first conversational AI oncology mentor.

Continue Reading >

More Articles

Medika’s Top 20 ’24 Influential Voices to Follow

Dave is the world’s first LLM conversational AI oncology mentor for cancer patients, bringing a…

Trialbee & Belong.Life Partner to Increase Clinical Trial Awareness and Enrollment

Trialbee, the global leader in technology-driven patient recruitment for clinical trials, is launching an Omnichannel…

More on Using AI to Enhance Cancer Care

Dave AI provides the cognitive assistant with organized and valuable information to be delivered in…
Skip to content